Please provide your email address to receive an email when new articles are posted on . In this episode, host Shikha Jain, MD, speaks with Opyl co-founder Damon Rasheed about using machine learning to ...
Clinical prediction models for schizophrenia treatment outcomes that work well within the trials from which they were developed fail to generalize to future trials, according to a new study. “The ...
Biomarkers associated with outcomes from KEYLYNK-010: Pembrolizumab (pembro) plus olaparib (ola) versus next-generation hormonal agent (NHA) in previously treated metastatic castration-resistant ...
A scoping review shows machine learning models may help predict response to biologic and targeted synthetic DMARDs in ...
Retail pharmacy giant Walgreens inked another partnership to recruit participants for research as it continues to build out its clinical trials business. The company signed a deal with Boehringer ...
BOSTON , Feb. 3, 2025 /PRNewswire/ -- PhaseV, a pioneer in software and machine learning (ML) for clinical trial optimization, announced today it has entered a strategic partnership with Alimentiv Inc ...
Clinical trials are frightening endeavors for biotech investors. Expensive and fraught with risk, a trial’s failure can seriously lighten an investor’s pockets with little hope of recourse. After ...
TrialTranslator uncovers the survival gap for high-risk patients and offers a path to better cancer research. Study: Evaluating generalizability of oncology trial results to real-world patients using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback